Ocugen (NASDAQ:OCGN) 株価情報

OCUGEN INC

Ocugen

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Ocugen Inc

Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) has outperformed the market over the past 5 years by 9.6% on an annualized basis producing an average annual return of 24.34%. Currently, Carvana has a market capitalization of $39.27 billion. 
Buying $1000 In CVNA: If an investor had bought $1000 of CVNA stock 5 years ago, it would be worth $3,162.75 today based on a price of $292.33 for CVNA at the time of writing.
<h3>Carvana's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747179011_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

CVNA

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

HealthEquity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) has outperformed the market over the past 10 years by 3.4% on an annualized basis producing an average annual return of 14.06%. Currently, HealthEquity has a market capitalization of $8.39 billion. 
Buying $1000 In HQY: If an investor had bought $1000 of HQY stock 10 years ago, it would be worth $3,740.46 today based on a price of $96.99 for HQY at the time of writing.
<h3>HealthEquity's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747178115_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning HealthEquity Stock In The Last 10 Years

Billionaire investor Mark Cuban took another shot at Commerce Secretary Howard Lutnick in his latest post. Over the weekend, Cuban took to <a href="https://bsky.app/profile/mcuban.bsky.social/post/3lovvp2fzcc2j">Bluesky</a> to mock Lutnick, writing, "I wonder which Time Share company Howard Lutnick is going to get a job in sales at."
<h2 class="wp-block-heading">Lutnick&#8217;s Controversial Tenure</h2>
Cuban&#8217;s jab comes on the heels of a series of critical comments he&#8217;s made about Lutnick's tenure as commerce secretary. In March, for instance, Cuban questioned Lutnick&#8217;s effectiveness, <a href="https://bsky.app/profile/mcuban.bsky.social/post/3lkxkj5mhnc2o">asking</a>, "Has Howard Lutnick done anything of value as Commerce Secretary?" The remark was a response to Lutnick&#8217;s recent controversial interviews and public comments.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
One of the key points of contention is Lutnick&#8217;s approach to tariffs and trade. In a March <a href="https://bsky.app/profile/atrupar.com/post/3ljpthdit7k24">CNBC</a> interview, Lutnick defended the Trump administration's tariff strategy, emphasizing its potential to boost U.S. manufacturing. Cuban shot back on <a href="https://bsky.app/profile/did:plc:y5xyloyy7s4a2bwfeimj7r3b/post/3ljqszshvvc2k">Bluesky</a>, saying, "Someone needs to explain to our Sec of Commerce how capitalism works." He added, "America has a global trade surplus on services. Services have the highest margins and profits of our exports. That is where capital and expertise are focused."
Cuban's critiques highlight a fundamental disagreement over the direction of U.S. trade policy. Lutnick has been a vocal supporter of President Donald Trump&#8217;s tariffs, arguing that they are necessary to address the $1.2 trillion U.S. trade deficit. He defended this approach in a Sunday <a href="https://www.youtube.com/watch?v=1lx5YKNttzU">CNN</a> interview, describing the deficit as unsustainable and claiming that tariffs will help create balanced trade. "The president wants balanced and fair trade, and tariffs are the tool to create balanced and fair trade," Lutnick said.
Trending: The team behind $6B+ in licensing deals is now building the next billion-dollar IP empire — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">invest early at $2.25/share.</a>
Cuban has consistently resisted this, arguing that the U.S. should concentrate more on its robust services industry, which he claims is more lucrative and a better long-term investment for economic expansion. He also criticized Lutnick&#8217;s recent comments about Social Security, where Lutnick suggested that people who complain about missed checks might be fraudsters, sparking significant backlash.
"My mother-in-law, who&#8217;s 94, she wouldn&#8217;t call and complain. She just wouldn&#8217;t," Lutnick said on the "<a href="https://www.youtube.com/watch?v=182ckTL2KBA">All-In Podcast</a>" in March. "A fraudster always makes the loudest noise, screaming, yelling and complaining."
The latest trade developments also add context to Cuban&#8217;s criticism. This week, the U.S. and China agreed to a <a href="https://www.benzinga.com/government/regulations/25/05/45342343/us-stock-futures-rise-as-us-china-agree-to-90-day-tariff-pause-wider-earnings-growth-should-drive-more-balanced-market-performance-says-expert">90-day tariff reduction pause</a>, with the U.S. lowering tariffs on Chinese goods from 145% to 30% and China cutting duties on U.S. products from 125% to 10%. The deal, which allows for ongoing economic discussions, underscores the ongoing challenges in balancing U.S. trade interests.
Cuban&#8217;s pointed comments suggest he remains skeptical of Lutnick's approach, framing it as disconnected from the <a href="https://www.benzinga.com/25/04/44756759/new-research-shows-donald-trumps-25-tariffs-could-cost-auto-companies-108billion-report">economic realities</a> faced by <a href="https://www.benzinga.com/news/25/03/44347512/wait-tariffs-are-just-a-tax-on-us-employee-shocked-as-small-business-owner-cuts-his-hours-because-of-the-tariffs">most Americans</a>. His critiques echo broader concerns about the <a href="https://www.benzinga.com/25/05/45254241/recession-could-originate-at-the-port-of-los-angeles-warns-economist-calling-tariff-decision-a-misapplied-consumption-tax-on-households">potential economic fallout</a> from ongoing trade disputes and the effectiveness of <a href="https://www.benzinga.com/personal-finance/25/05/45338243/stephen-miller-says-history-will-record-trumps-tariffs-as-the-start-of-saving-the-west-from-chinas-economic-domination">tariffs as a long-term strategy</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li><a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a></li>
</ul>
Image: Shutterstock

Mark Cuban Takes A Jab At Howard Lutnick, 'In Which Time Share Company Is He Going To Get A Job In Sales At'

Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) has outperformed the market over the past 5 years by 4.68% on an annualized basis producing an average annual return of 19.42%. Currently, Microsoft has a market capitalization of $3.33 trillion. 
Buying $1000 In MSFT: If an investor had bought $1000 of MSFT stock 5 years ago, it would be worth $2,452.17 today based on a price of $448.40 for MSFT at the time of writing.
<h3>Microsoft's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747177210_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSFT

$1000 Invested In Microsoft 5 Years Ago Would Be Worth This Much Today

Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) has outperformed the market over the past 15 years by 9.66% on an annualized basis producing an average annual return of 21.35%. Currently, Chipotle Mexican Grill has a market capitalization of $68.30 billion. 
Buying $100 In CMG: If an investor had bought $100 of CMG stock 15 years ago, it would be worth $1,813.33 today based on a price of $50.69 for CMG at the time of writing.
<h3>Chipotle Mexican Grill's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747176317_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Chipotle Mexican Grill Stock In The Last 15 Years

Wall Street extended its rally on Tuesday as easing trade tensions between the U.S. and China and softer inflation data boosted investor confidence. In fact, the S&amp;P 500 reclaimed positive territory for 2025 and closed 0.7%<a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45379707/sp-500-to-6500-goldman-sachs-trims-recession-odds-as-trump-backs-off-on-tariffs"> higher on the day.</a>&nbsp;
What To Know: The market is flashing another bullish signal that could indicate even more gains ahead, according to Ryan Detrick, chief market strategist for the Carson Group.&nbsp;
Detrick observed that on Tuesday, more than 60% of the components in the S&amp;P 500 are hitting new 20-day highs and pointed to a historically bullish year following this rare occurrence. 
Read Next: <a href="https://www.benzinga.com/25/05/45378427/trump-wants-to-kickstart-nuclear-development-these-5-stocks-could-boom?utm_source=articleShare">Trump Wants To Kickstart Nuclear Development: These 5 Stocks Could Boom</a>
"This is quite rare and rather bullish. Strong performance across the board and higher a year later 18 out of 18 times," Detrick wrote<a href="https://x.com/RyanDetrick/status/1922361671332303080"> in a post</a> on X.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">After today we will have more than 60% of the components in the S&amp;P 500 hitting a new 20-day high. This is quite rare and rather bullish. Strong performance across the board and higher a year later 18 out of 18 times. &#x1f4aa; <a href="https://t.co/0D4Pm0scqS">pic.twitter.com/0D4Pm0scqS</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1922361671332303080?ref_src=twsrc%5Etfw">May 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Detrick posted a chart from Carson Investment Research, which shows the last time more than 60% of S&amp;P 500 components reached a new 20-day high was on Dec. 1, 2023. Twelve months later, the S&amp;P 500 was 31.7% higher. 
The same chart indicates that this signal has flashed 18 times since 1982, and each time the S&amp;P 500 was higher 12 months later with an average gain of 18.6%.&nbsp;
What Drove The Action: First Solar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) soared almost 23% and was the biggest gainer in the S&amp;P 500 on Tuesday, on favorable U.S.<a href="https://www.benzinga.com/top-stories/25/05/45381191/first-solar-eyes-best-2-day-rally-since-2013-after-gop-tax-plan-spares-key-clean-energy-credits"> policy developments</a> for domestic solar manufacturers. 
NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) was a standout performer Tuesday, surging nearly 6% after announcing it <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45384348/whats-going-on-with-nvidia-stock-tuesday-2">would supply </a>18,000 advanced AI chips to Saudi Arabia. The move pushed Nvidia&#8217;s market capitalization above $3 trillion and made it a major force behind the S&amp;P 500&#8217;s advance. 
Shares of Palantir Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) rose more than 8% to an all-time high of $130.60, <a href="https://www.benzinga.com/news/25/05/45383727/palantir-stock-hits-new-all-time-high-on-strong-earnings-macro-tailwinds">buoyed by optimism</a> around its AI software and increased defense sector opportunities. 
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45354683/tesla-probably-wont-make-money-on-ride-hailing-for-years-gary-black-says?utm_source=articleShare">Tesla Robotaxi Hopes Dashed By Uber, Lyft: No Fast Lane To Profits, Warns Investor Gary Black&nbsp;</a></li>
</ul>
Image: Shutterstock

Analyst Color

Equities

Broad U.S. Equity ETFs

Markets

ETFs

FSLR

NVDA

PLTR

S&P 500 Turns Positive On The Year, Flashes 'Quite Rare And Rather Bullish' Signal

TherapeuticsMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXMD#NASDAQ">TXMD</a>) reported quarterly losses of $(0.06) per share. This is a 14.29 percent increase over losses of $(0.07) per share from the same period last year. The company reported $393.00 thousand in sales this quarter. This is a 25.56 percent increase over sales of $313.00 thousand the same period last year.

Earnings

TXMD

TherapeuticsMD Q1 EPS $(0.06) Up From $(0.07) YoY, Sales $393.00K Up From $313.00K YoY

Sen. Bernie Sanders (I-VT) says American workers are frustrated and they have a good reason to be.&nbsp;
In a recent <a href="https://x.com/BernieSanders/status/1919106487508414676">post on X</a>, Sanders pointed out that despite decades of rising worker productivity, inflation-adjusted wages are lower today than they were 52 years ago. At the same time, he noted a massive transfer of wealth from the bottom 90% to the top 1%, calling the situation unacceptable. "The status quo is NOT working. We need real change," he wrote.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">American workers are angry. Despite increased worker productivity, inflation-adjusted wages are lower today than they were 52 years ago. At the same time, there was a huge transfer of wealth from the bottom 90% to the top 1%. The status quo is NOT working. We need real change.
&mdash; Bernie Sanders (@BernieSanders) <a href="https://twitter.com/BernieSanders/status/1919106487508414676?ref_src=twsrc%5Etfw">May 4, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">A Growing Gap Between Productivity and Pay</h2>
The Economic Policy Institute backs up Sanders&#8217; claims. According to a recent EPI <a href="https://www.epi.org/productivity-pay-gap/">report</a>, U.S. productivity has surged by 86.5% from 1979 to 2024, while hourly pay for typical workers only grew by 31.7% over the same period. That means productivity has grown nearly three times faster than wages, creating a wide gap between the value workers produce and what they take home.
The EPI argues this gap is not an accident but a result of policy decisions that reduced worker bargaining power, <a href="https://www.benzinga.com/news/25/01/42918620/unions-should-brace-for-competition-what-trumps-labor-revolution-means-for-workers">weakened unions</a>, and shifted more wealth to capital owners. The report points out that this shift has resulted in slower economic growth overall, with typical workers missing out on the benefits of rising productivity.
"The growing wedge between productivity and typical workers' pay is income going everywhere but the paychecks of the bottom 80% of workers," the EPI said. "If it didn't end up in paychecks of typical workers, where did all the income growth implied by the rising productivity line go? Two places, basically. It went into the salaries of highly paid corporate and professional employees. And it went into higher profits (returns to shareholders and other wealth owners)."
Trending: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
<h2 class="wp-block-heading">Longer Hours, Shorter Lives</h2>
Sanders has also recently <a href="https://www.benzinga.com/news/25/03/44302734/bernie-sanders-says-stress-kills-as-he-highlights-a-7-year-life-expectancy-gap-between-the-working-class-and-the-wealthy">raised concerns about the health impact</a> of economic stress. In a recent <a href="https://www.sanders.senate.gov/wp-content/uploads/3.7.2025-Life-Expectancy-Working-Class-Report_final.pdf">report</a> from the Senate Committee on Health, Education, Labor and Pensions, he highlighted a growing life expectancy gap between the wealthy and the working class. The report found that Americans in the wealthiest 1% of counties live an average of 84.3 years, while those in the bottom 50% of counties live only 77.4 years.
One stark example from the report shows that Loudoun County, Virginia, one of the wealthiest counties in the U.S., has a life expectancy of 84 years, while McDowell County, West Virginia, one of the poorest, has a life expectancy of just 69 years—a 15-year difference despite being only about 350 miles apart.
"Stress kills," Sanders said, adding that these disparities are unacceptable in a wealthy country like the U.S. "The massive <a href="https://www.benzinga.com/personal-finance/25/01/43351521/2025-is-the-year-the-wealth-disparity-gets-much-worse-viral-finance-influencer-explains-the-trump-economic-effect">income and wealth inequality</a> that exists in America today is not just an economic issue, it is literally a matter of life and death."
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a>
<h2 class="wp-block-heading">Closing the Gap</h2>
To address these issues, Sanders has proposed a series of policy changes aimed at boosting workers&#8217; pay and improving their quality of life. These include <a href="https://in.benzinga.com/news/25/04/45028145/joe-rogan-agrees-with-bernie-sanders-saying-hes-right-that-you-should-be-scared-of-oligarchs-they-shouldnt-be-running-the-government">raising the minimum wage to at least $17 an hour</a>, implementing Medicare for All, expanding Social Security, providing paid family leave, and making education more affordable.
Sanders argues that these steps are essential if the U.S. is to close the growing gap between the rich and the working class and ensure that all Americans can share in the nation&#8217;s prosperity.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Bernie Sanders Says 'American Workers Are Angry' Because Wages Haven't Kept Up—'They Are Lower Today Than They Were 52 Years Ago'

UMB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UMBF#NASDAQ">UMBF</a>) has outperformed the market over the past 5 years by 3.2% on an annualized basis producing an average annual return of 17.95%. Currently, UMB Financial has a market capitalization of $8.20 billion. 
Buying $1000 In UMBF: If an investor had bought $1000 of UMBF stock 5 years ago, it would be worth $2,487.10 today based on a price of $107.99 for UMBF at the time of writing.
<h3>UMB Financial's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747175410_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

UMBF

$1000 Invested In UMB Financial 5 Years Ago Would Be Worth This Much Today

Flora Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGC#NASDAQ">FLGC</a>) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.16) by 75 percent. This is a 89.47 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $11.79 million which missed the analyst consensus estimate of $15.42 million by 23.55 percent. This is a 34.63 percent decrease over sales of $18.03 million the same period last year.

Earnings Beats

Earnings Misses

FLGC

Flora Growth Q1 EPS $(0.04) Beats $(0.16) Estimate, Sales $11.79M Miss $15.42M Estimate

Anebulo Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANEB#NASDAQ">ANEB</a>) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. This is a 33.33 percent increase over losses of $(0.06) per share from the same period last year.

ANEB

Anebulo Pharmaceuticals Q3 EPS $(0.04) Beats $(0.05) Estimate

Lightwave Logic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWLG#NASDAQ">LWLG</a>) reported quarterly losses of $(0.04) per share. This is a 20 percent increase over losses of $(0.05) per share from the same period last year. The company reported $22.92 thousand in sales this quarter. This is a 24.66 percent decrease over sales of $30.42 thousand the same period last year.

LWLG

Lightwave Logic Q1 EPS $(0.04) Up From $(0.05) YoY, Net Sales $22.92K Down From $30.42K YoY

Ambase (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ABCP#OTC">ABCP</a>) reported quarterly losses of $(0.02) per share. This is a 60 percent increase over losses of $(0.05) per share from the same period last year.

ABCP

Ambase Q1 EPS $(0.02) Up From $(0.05) YoY

Satellogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) reported quarterly losses of $(0.34) per share. This is a 100 percent decrease over losses of $(0.17) per share from the same period last year. The company reported $3.39 million in sales this quarter. This is a 1.77 percent increase over sales of $3.33 million the same period last year.

SATL

CORRECTION: Satellogic Q1 EPS $(0.34) Down From $(0.17) YoY, Sales $3.39M Up From $3.33M YoY

McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) has outperformed the market over the past 20 years by 3.89% on an annualized basis producing an average annual return of 12.19%. Currently, McDonald's has a market capitalization of $220.59 billion. 
Buying $1000 In MCD: If an investor had bought $1000 of MCD stock 20 years ago, it would be worth $9,967.39 today based on a price of $308.75 for MCD at the time of writing.
<h3>McDonald's's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747174516_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In McDonald's 20 Years Ago Would Be Worth Today

Chardan Capital analyst Keay Nakae maintains Orchestra BioMed Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBIO#NASDAQ">OBIO</a>) with a Buy and maintains $20 price target.

Price Target

Analyst Ratings

Orchestra BioMed Holdings, Inc. - Ordinary Shares

OBIO

Chardan Capital Maintains Buy on Orchestra BioMed Hldgs, Maintains $20 Price Target

Chardan Capital analyst Keay Nakae maintains Korro Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRRO#NASDAQ">KRRO</a>) with a Buy and maintains $25 price target.

KRRO

Chardan Capital Maintains Buy on Korro Bio, Maintains $25 Price Target

General

EXEL

Invenra's Collaboration Partner Exelixis Initiates The Dose-Escalation Stage Of The First-In-Human Phase 1 Clinical Study Of XB628 In Participants With Recurrent Advanced Or Metastatic Solid Tumors

Reality competition "Beast Games"<a href="https://www.benzinga.com/general/entertainment/24/03/37809533/mrbeast-confirms-beast-games-on-amazon-prime-video-with-1-000-contestants-5m-prize-its-gonn"> from the mind of</a> content creator MrBeast is returning for two more seasons on Prime Video, the streaming platform from Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
MrBeast says he hopes this time the show doesn't lose him as much money, but he promises to make it bigger than the first season.
What Happened: A first season of "Beast Games" set several records, including 44 Guinness World Records, and had a massive $10 million payout to the winner from 1,000 contestants, but also created a <a href="https://www.benzinga.com/general/entertainment/25/02/43903423/mrbeast-calls-his-amazon-deal-for-beast-games-a-financial-mistake-this-is-the-price-you-have-to-pay">financial loss for MrBeast.</a>
The content creator, also known as Jimmy Donaldson, announced on social media that "Beast Games" has been renewed for two more seasons with Prime Video.
"Y'all are not ready for the big stuff we have planned," MrBeast <a href="https://x.com/MrBeast/status/1922068781058109819">said </a>in the post.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Prime video has renewed Beast Games for not one but TWO MORE SEASONS!! Y'ALL ARE NOT READY FOR THE BIG STUFF WE HAVE PLANNED &#x1f970;&#x1f970;&#x1f970; <a href="https://t.co/oc5hWKBEnq">pic.twitter.com/oc5hWKBEnq</a>
&mdash; MrBeast (@MrBeast) <a href="https://twitter.com/MrBeast/status/1922068781058109819?ref_src=twsrc%5Etfw">May 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
A user asked MrBeast how he can make the show "go bigger" without the fear of going bankrupt, while asking about his loss on the first season.
"Going bigger is my specialty, that's the least of my concerns haha. Yeah, ideally don't lose 8 figures though," MrBeast replied.
The first season was the most-watched unscripted series on Prime Video, according to a <a href="https://variety.com/2025/tv/news/mrbeast-beast-games-renewed-two-seasons-prime-video-1236392387/">report </a>from Variety. The series had 50 million viewers in the first 25 days after its Dec. 19 premiere.
MrBeast has 32.5 million followers on X and 394 million subscribers on YouTube, ranking as the top followed account on the video platform.
The popularity of the content creator helped boost viewership for Prime Video and could do the same for two more seasons.
Read Also: <a href="https://www.benzinga.com/general/entertainment/24/05/38860861/amazon-betting-on-game-shows-for-streaming-growth-mrbeast-travis-kelce-pop-culture-jeopardy">Amazon Betting On Game Shows For Streaming Growth: MrBeast, Travis Kelce, Pop Culture Jeopardy And More</a>
What's Next: Based on the "Beast Games" <a href="https://www.beastgames.com/">website</a>, it looks like season 2 is still casting. The website says casting is open to people aged 18 or older who can legally travel and re-enter the U.S. for up to six consecutive weeks during the period of May to July 2025.
Contestants must also be free of any obligations including personal, family or work during the designated time period of filming for the show. Another interesting casting nugget is that any current candidates for public office or people intending to run for public office within one year as of July 1, 2026, can not participate in the show.
To get cast on the second season of "Beast Games," contestants need to submit their information along with a one-minute video about themselves that includes answers to some of the following questions:
<ul class="wp-block-list">
<li>"What was your favorite challenge from BEAST GAMES Season 1, and why?</li>
<li>"Who was your favorite contestant from Season 1, and what made them stand out to you?</li>
<li>"What makes you an unforgettable competitor?"</li>
<li>"What would you do with $5,000,000?"</li>
</ul>
Contestants on "Beast Games" are tested with challenges that are physical, mental and social and are also offered bribes to leave the game along the way.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/03/44543735/mrbeast-is-writing-a-squid-game-style-thriller-and-media-companies-are-ready-to-bid-eight-figures-for-the-rights">MrBeast Is Writing A &#8216;Squid Game&#8217; Style Thriller And Media Companies Are Ready To Bid Eight-Figures For The Rights</a></li>
</ul>
Photo: Joe Seer via Shutterstock

Entertainment

Media

AMZN

MrBeast Teases Two More Seasons Of 'Beast Games' After Losing Millions: 'Ideally Don't Lose 8 Figures'

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COYA#NASDAQ">COYA</a>) with a Buy and maintains $14 price target.

COYA

Chardan Capital Maintains Buy on Coya Therapeutics, Maintains $14 Price Target

Health Care

Press Releases

Ocugen, Inc. Announces FDA Alignment on Phase 2/3 Pivotal Confirmatory Clinical Trial for Modifier Gene Therapy Candidate OCU410ST for Stargardt Disease

Legal

Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Ocugen, Inc. (NASDAQ: OCGN)

Biotech

Ocugen Announces Positive Opinion of EMA's Committee for Advanced Therapies for ATMP Classification for Novel Modifier Gene Therapy Candidate OCU410 for Geographic Atrophy and OCU410ST for Stargardt Disease

Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results

Attention Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); MGP Ingredients, Inc. (NASDAQ: MGPI); and Ocugen, Inc. (NASDAQ: OCGN): Grabar Law Office Investigates Claims on Your Behalf

Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema

Ocugen to Present at the 2025 Cell & Gene Meeting on the Med

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress

Comments

Ocugen

ニュース

パートナーシップ

ベンジンガ・グローバル